---
title: "Cabio Biotech (Wuhan) Full Year 2024 Earnings: Beats Expectations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233708771.md"
description: "Cabio Biotech (Wuhan) reported its Full Year 2024 earnings, with revenue of CN¥555.6m, a 25% increase from FY 2023, and net income of CN¥124.2m, up 36%. The profit margin rose to 22%, and EPS increased to CN¥0.74. Both revenue and EPS exceeded analyst expectations. Future revenue is projected to grow 18% annually over the next two years, outpacing the Chemicals industry forecast of 16%. However, shares have declined by 2.7% in the past week, and there are two warning signs to consider."
datetime: "2025-03-29T02:56:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233708771.md)
  - [en](https://longbridge.com/en/news/233708771.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233708771.md)
generator: "portal-rs"
---

# Cabio Biotech (Wuhan) Full Year 2024 Earnings: Beats Expectations

## Cabio Biotech (Wuhan) (SHSE:688089) Full Year 2024 Results

### Key Financial Results

-   Revenue: CN¥555.6m (up 25% from FY 2023).
-   Net income: CN¥124.2m (up 36% from FY 2023).
-   Profit margin: 22% (up from 21% in FY 2023). The increase in margin was driven by higher revenue.
-   EPS: CN¥0.74 (up from CN¥0.54 in FY 2023).

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

SHSE:688089 Earnings and Revenue Growth March 29th 2025

*All figures shown in the chart above are for the trailing 12 month (TTM) period*

### Cabio Biotech (Wuhan) Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) also surpassed analyst estimates by 5.7%. 

Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. 

*Performance of the **Chinese Chemicals industry.***

The company's shares are down 2.7% from a week ago. 

### Risk Analysis

Before you take the next step you should know about the **2 warning signs for Cabio Biotech (Wuhan)** that we have uncovered.

### Related Stocks

- [688089.CN](https://longbridge.com/en/quote/688089.CN.md)

## Related News & Research

- [Global Brain leads investment in cancer detection startup MiRNDa](https://longbridge.com/en/news/296842692.md)
- [My Mountain Mover Recognized Among the 2026 Inc. 5000 Fastest-Growing U.S. Companies](https://longbridge.com/en/news/297087696.md)
- [MDI: Revenue up 17% year-over-year, with strong pipeline but profit after tax down 3.9%](https://longbridge.com/en/news/296862415.md)
- [Citi Downgrades COSCO SHIP HOLD , Evergreen Marine and Yang Ming to Neutral, Adjusts TPs](https://longbridge.com/en/news/296859156.md)
- [Panda Express’ CEOs are on a ‘mission’ to help workers achieve the dream of home ownership](https://longbridge.com/en/news/297055215.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**